BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38599663)

  • 1. The reported impact of non-communicable disease investment cases in 13 countries.
    Troisi G; Small R; Chestnov R; Andreasyan D; Khachatryan H; Phillips EA; Malcolm T; Kol H; Khodjaeva N; Gebremichael M; Worku Tessema A; Workneh AB; Davidson T; Harris M; Ibraeva N; Nurmatova A; Altymysheva A; Go JJ; Kontsevaya A; Hanbunjerd K; Bunluesin S; Nieveras O; Ekinci B; KeskinkiliƧ B; Erguder T; Akiya OC; Kasule H; Nakanjako A; Shukurov S; Kasymova N; Banda P; Kakoma E; Bakyaita NN; Kulikov A; Tarlton D; Putoud N; Chiossi S; Webb D; Banatvala N
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38599663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The process of prioritization of non-communicable diseases in the global health policy arena.
    Heller O; Somerville C; Suggs LS; Lachat S; Piper J; Aya Pastrana N; Correia JC; Miranda JJ; Beran D
    Health Policy Plan; 2019 Jun; 34(5):370-383. PubMed ID: 31199439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
    Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
    PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening implementation of diet-related non-communicable disease prevention strategies in Fiji: a qualitative policy landscape analysis.
    Mounsey S; Waqa G; McKenzie B; Reeve E; Webster J; Bell C; Thow AM
    Global Health; 2022 Sep; 18(1):79. PubMed ID: 36050736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China's Efforts on Management, Surveillance, and Research of Noncommunicable Diseases: NCD Scorecard Project.
    Zhu XL; Luo JS; Zhang XC; Zhai Y; Wu J
    Ann Glob Health; 2017; 83(3-4):489-500. PubMed ID: 29221521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored support for national NCD policy and programme implementation: an over-looked priority.
    Jackson-Morris A; Nugent R
    BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32847822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-communicable disease prevention policy process in five African countries.
    Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
    Allen LN; Wigley S; Holmer H; Barlow P
    Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curbing the Rise of Noncommunicable Diseases in Uganda: Perspectives of Policy Actors.
    Meghani A; Ssemugabo C; Pariyo G; Hyder AA; Rutebemberwa E; Gibson DG
    Glob Health Sci Pract; 2021 Mar; 9(1):149-159. PubMed ID: 33795366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigating the Rising Burden of Non-Communicable Diseases through Locally Generated Evidence-Lessons from Tanzania.
    Ndumwa HP; Amani DE; Ngowi JE; Njiro BJ; Munishi C; Mboya EA; Mloka D; Kikula AI; Balandya E; Ruggajo P; Kessy AT; Kitambala E; Kapologwe N; Kengia JT; Kiologwe J; Ubuguyu O; Salum B; Kamuhabwa A; Ramaiya K; Sunguya BF
    Ann Glob Health; 2023; 89(1):77. PubMed ID: 38025921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases.
    Suzuki M; Webb D; Small R
    Int J Health Policy Manag; 2022 Jul; 11(7):1078-1089. PubMed ID: 33619925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Development of Public Policies to Address Non-communicable Diseases in the Caribbean Country of Barbados: The Importance of Problem Framing and Policy Entrepreneurs.
    Unwin N; Samuels TA; Hassell T; Brownson RC; Guell C
    Int J Health Policy Manag; 2017 Feb; 6(2):71-82. PubMed ID: 28812782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of non-communicable diseases policies in post-apartheid South Africa.
    Ndinda C; Ndhlovu TP; Juma P; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):956. PubMed ID: 30168397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
    Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
    BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responding to non-communicable diseases in Zambia: a policy analysis.
    Mukanu MM; Zulu JM; Mweemba C; Mutale W
    Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamic of non-communicable disease control policy in Indonesia.
    Christiani Y; Dugdale P; Tavener M; Byles JE
    Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.